Knowledge, Perceptions, and Attitudes of Israeli Healthcare Professionals Toward Mpox: A Survey-Based, Cross-Sectional Study
Authors:
- Rola Khamisy-FarahRKRola Khamisy-Farah
- Raymond FarahRFRaymond Farah
- Hisham AtwanHAHisham Atwan
- Rabie ShehadehRSRabie Shehadeh
- Inshirah Sgayer ShannanISInshirah Sgayer Shannan
- Corinne TopchiCTCorinne Topchi
- Yara MoallemYMYara Moallem
- Basem HijaziBHBasem Hijazi
- Najim Z. AlshahraniNajim Z. Alshahrani
- Woldegebriel Assefa WoldegerimaWWWoldegebriel Assefa Woldegerima
- Nicola Luigi BragazziNicola Luigi Bragazzi
Open Access
- 1 April 2025
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 13 (7) , 790
Abstract
Background: Mpox, a zoonotic viral disease, has recently emerged as a significant global public health challenge. Historically confined to endemic regions in West and Central Africa, recent outbreaks in non-endemic areas have highlighted the critical role of healthcare professionals (HCPs) in disease management and prevention. Methods: This cross-sectional study surveyed 709 Israeli HCPs, with a mean age of 40.6 ± 9.4 years, to evaluate their knowledge, perceptions, and attitudes toward mpox and identify gaps to inform educational and public health strategies. Results: Findings revealed that only 38.9% of respondents demonstrated good knowledge about mpox, while 61.1% exhibited poor knowledge. Misconceptions were prevalent: 37.9% identified paracetamol as a management option, with only 31.0% recognizing the need for antivirals. Notably, 67.1% correctly identified mpox as a viral disease, yet only 47.2% were aware that lymphadenopathy is a distinguishing symptom. Multivariable analysis identified several predictors of good knowledge, including marital status, being a medical doctor (versus an allied health professional), work seniority, and previous exposure to mpox-related information. Attitudes varied, with 57.7% expressing confidence in the ability of global health authorities to control mpox, and 59.0% expressing confidence in the Israeli Ministry of Health. Interest in learning more about mpox and related topics was high, with 67.4% showing interest in the epidemiology of emerging diseases. Respondents with good knowledge consistently exhibited more positive attitudes and confidence in managing mpox-related challenges. Conclusions: These findings underscore the urgent need for targeted educational interventions to enhance HCPs’ readiness and response capabilities. Strengthening professional training, incorporating emerging infectious diseases into curricula, and leveraging accurate media communication are critical steps toward improving preparedness for mpox and future outbreaks.Keywords
Funding Information
- Canadian Institute for Health Research (CIHR) (187246, RGPIN-2023-05100)
- NSERC Discovery Grant (187246, RGPIN-2023-05100)
This publication has 30 references indexed in Scilit:
- Assessment of knowledge and attitude of healthcare professionals towards Mpox in a Nigerian hospitalScientific Reports, 2024
- Spatiotemporal cluster of mpox in men who have sex with men: A modeling study in 83 countriesJournal of Medical Virology, 2023
- The roles and challenges of the primary health care systems in epidemic management: a scoping reviewPrimary Health Care Research & Development, 2023
- Clinical review of human mpoxClinical Microbiology and Infection, 2023
- Monkeypox outbreak in the Tel Aviv District, Israel, 2022International Journal of Infectious Diseases, 2022
- MonkeypoxNew England Journal of Medicine, 2022
- Is monkeypox a new, emerging sexually transmitted disease? A rapid review of the literatureJournal of Medical Virology, 2022
- The 2022 outbreak and the pathobiology of the monkeypox virusJournal of Autoimmunity, 2022
- Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature reviewJournal of Medical Virology, 2022
- Infectious Diseases: The Role of the Healthcare Professional2020